{"id":1274,"date":"2026-04-16T20:11:25","date_gmt":"2026-04-17T00:11:25","guid":{"rendered":"https:\/\/health.uconn.edu\/molecular-oncology\/?page_id=1274"},"modified":"2026-09-15T09:13:07","modified_gmt":"2026-09-15T13:13:07","slug":"faculty-new","status":"publish","type":"page","link":"https:\/\/health.uconn.edu\/molecular-oncology\/faculty-new\/","title":{"rendered":"Faculty"},"content":{"rendered":"
\n

This Website Is Currently Undergoing Maintenance. <\/span>Thank You For Your Patience.<\/span><\/span><\/h2>\n<\/div>\n
\n

\"UConn<\/a><\/h1>\n

Our Faculty<\/h1>\n
\n

Meet the Physician-Scientists and researchers driving molecular oncology discovery at UConn Health \u2014 from bench to bedside.<\/p>\n

 <\/p>\n<\/div>\n

\n<\/div>\n

<\/p>\n

\n

Faculty Members<\/span><\/h2>\n<\/div>\n
\n
<\/div>\n
\n
\n

\"Andrew<\/a><\/span><\/span><\/span><\/p>\n

Andrew Arnold, M.D.<\/span><\/div>\n
\n
Director, Center for Molecular Oncology and Chief Academic Officer, Carole and Ray Neag Comprehensive Cancer Center<\/span><\/strong><\/span><\/div>\n

Endocrine Tumors \u00b7 Cyclin D1 Oncogene \u00b7 Breast Cancer<\/span><\/span><\/p>\n

Pathogenesis of parathyroid and other endocrine tumors, and role of the cyclin D1 oncogene in neoplasia, including breast cancer.<\/span><\/span><\/p>\n<\/div>\n<\/div>\n

<\/div>\n
View Full Profile \u2192<\/a>Contact The Director \u2192<\/a><\/span><\/div>\n
<\/div>\n
<\/div>\n
<\/div>\n<\/div>\n<\/div>\n
<\/div>\n
<\/div>\n
<\/div>\n
\n
\"Christopher<\/a>Christopher D. Heinen, Ph.D.<\/span><\/span><\/div>\n
Colorectal Cancer \u00b7 DNA Mismatch Repair \u00b7 Organoid Models<\/span><\/div>\n
<\/div>\n
The molecular biology of colorectal cancer. Understanding the functions of the DNA mismatch repair system affected during tumorigenesis using biochemical, cell culture and human organoid models.<\/span><\/div>\n

 <\/p>\n

View Full Profile \u2192<\/a><\/span><\/div>\n
<\/div>\n<\/div>\n
<\/div>\n
\n
\"Anne<\/a>Anne Delany, Ph.D.<\/span><\/span><\/div>\n
Bone Remodeling \u00b7 Tumor Microenvironment \u00b7 Metastasis<\/span><\/div>\n
<\/div>\n
Study of non-collagen matrix proteins in normal bone remodeling and the impact of microenvironment on tumor development and metastasis.<\/span><\/div>\n

 <\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/div>\n<\/div>\n
\n
\"Daniel<\/a>Daniel Rosenberg, Ph.D. <\/span><\/span><\/div>\n
Gastrointestinal Cancer \u00b7 Toxicogenomics \u00b7 Environmental Carcinogenesis<\/span><\/div>\n
<\/div>\n
Pathogenesis of gastrointestinal cancer, toxicogenomics, mouse tumor models, environmental carcinogenesis, altered signaling pathways in cancer cells.<\/span><\/div>\n

 <\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/span><\/div>\n<\/div>\n
\n
\"Marc<\/a>Marc Hansen, Ph.D.<\/span><\/span><\/div>\n
Bone Tumors \u00b7 Tumor Suppressor Genes \u00b7 Paget’s Disease<\/span><\/div>\n
<\/div>\n
Pathogenesis of bone tumors, the role of tumor suppressor genes in neoplasia and development. Genetics of Paget’s disease of bone.<\/span><\/div>\n

 <\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/span><\/div>\n
<\/div>\n<\/div>\n
\n
\"Jessica<\/a>Jessica Costa, D.M.D., Ph.D.<\/span><\/span><\/div>\n
Craniofacial Tumors \u00b7 HRPT2\/CDC73 Tumor Suppressor<\/span><\/div>\n
<\/div>\n
Pathogenesis of craniofacial tumors and the role of the HRPT2\/CDC73 tumor suppressor gene in neoplasia.<\/span><\/div>\n

 <\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/span><\/div>\n
<\/div>\n<\/div>\n

<\/p>\n

\n
<\/div>\n
\"Masako<\/a>Masako Nakanishi, Ph.D.<\/span><\/div>\n
GI Inflammation \u00b7 Lipid Metabolism \u00b7 Microbiome\u00a0<\/span><\/span><\/span><\/span><\/span><\/div>\n
\n

Pathogenesis of gastrointestinal inflammation and cancer, mouse tumor models, the role of lipid metabolism, microbiome, nutritional intervention.<\/span><\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/span><\/p>\n<\/div>\n<\/div>\n

\n
\"Abhijit<\/a>Abhijit Rath, Ph.D. <\/span><\/span><\/div>\n
Lynch Syndrome \u00b7 CRISPR-Cas Gene Editing \u00b7 DNA Repair<\/span><\/div>\n
<\/div>\n
Modeling Lynch syndrome associated DNA mismatch repair gene variants in human embryonic stem cells using CRISPR-Cas gene editing. Functional testing of engineered cell lines for better stratification of Lynch syndrome patients.<\/span><\/div>\n

 <\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/span><\/span><\/div>\n<\/div>\n
\n
\"Suzy<\/a>Suzy V. Torti, Ph.D. <\/span><\/span><\/div>\n
Iron Metabolism \u00b7 Breast Cancer \u00b7 Nanomaterials<\/span><\/div>\n
\n

Molecular and cell biology of iron metabolism in breast cancer and other malignancies. Investigating the use of nanomaterials as anticancer agents.<\/span><\/p>\n

View Full Profile \u2192<\/a><\/span><\/span><\/span><\/span><\/p>\n<\/div>\n<\/div>\n

<\/p>\n

\n
\n

\"UConn<\/h2>\n

 <\/p>\n

Interested in research opportunities or collaborations with the Center for Molecular Oncology? We welcome inquiries from all students, trainees, and colleagues.<\/span><\/p>\n

Contact Us<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

This Website Is Currently Undergoing Maintenance. Thank You For Your Patience. Our Faculty Meet the Physician-Scientists and researchers driving molecular oncology discovery at UConn Health \u2014 from bench to bedside.   Faculty Members Andrew Arnold, M.D. Director, Center for Molecular Oncology and Chief Academic Officer, Carole and Ray Neag Comprehensive Cancer Center Endocrine Tumors \u00b7 […]<\/p>\n","protected":false},"author":7323,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-24 04:11:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/1274"}],"collection":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/users\/7323"}],"replies":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/comments?post=1274"}],"version-history":[{"count":58,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/1274\/revisions"}],"predecessor-version":[{"id":1860,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/1274\/revisions\/1860"}],"wp:attachment":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/media?parent=1274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}